BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11571741)

  • 1. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.
    Azzarelli A; Gronchi A; Bertulli R; Tesoro JD; Baratti D; Pennacchioli E; Dileo P; Rasponi A; Ferrari A; Pilotti S; Casali PG
    Cancer; 2001 Sep; 92(5):1259-64. PubMed ID: 11571741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
    Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A
    Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
    Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
    Acta Oncol; 2011 Apr; 50(3):455-61. PubMed ID: 20799916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
    Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A
    Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors].
    Fan Z; Li S; Fang Z; Liu J; Bai C; Xue R; Zhang L; Gao T
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):39-43. PubMed ID: 26806736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
    Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE;
    J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive fibromatosis in children and adolescents: the Italian experience.
    Meazza C; Bisogno G; Gronchi A; Fiore M; Cecchetto G; Alaggio R; Milano GM; Casanova M; Carli M; Ferrari A
    Cancer; 2010 Jan; 116(1):233-40. PubMed ID: 19950127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis.
    Park KH; Choi YJ; Kim KW; Ro KH; Kang CH; Song SH; Park JH
    Jpn J Clin Oncol; 2016 Sep; 46(9):845-9. PubMed ID: 27365524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of multifocal aggressive fibromatosis with low-dose chemotherapy.
    Caglar K; Ozyönüm H; Akalin M; Balci S
    Turk J Pediatr; 2006; 48(4):365-8. PubMed ID: 17290575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial.
    Nishida Y; Hamada S; Urakawa H; Ikuta K; Sakai T; Koike H; Ito K; Emoto R; Ando Y; Matsui S
    Cancer Sci; 2020 Nov; 111(11):4187-4194. PubMed ID: 32816351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
    Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of desmoid tumors and fibromatosis using vinorelbine.
    Weiss AJ; Horowitz S; Lackman RD
    Am J Clin Oncol; 1999 Apr; 22(2):193-5. PubMed ID: 10199460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Facial infantile aggressive fibromatosis: a frequent localization of an exceptional tumor!].
    Bouguila J; Khonsari RH; Zitouni K; Zairi I; Adouani A
    Ann Chir Plast Esthet; 2012 Jun; 57(3):304-7. PubMed ID: 20561731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors.
    Reich S; Overberg-Schmidt US; Bührer C; Henze G
    J Clin Oncol; 1999 Mar; 17(3):1086. PubMed ID: 10071306
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination chemotherapy in adult desmoid tumors.
    Patel SR; Evans HL; Benjamin RS
    Cancer; 1993 Dec; 72(11):3244-7. PubMed ID: 8242548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analysis of treatment of aggressive fibromatosis using oral methotrexate chemotherapy.
    Yoon GW; Kim JD; Chung SH
    Clin Orthop Surg; 2014 Dec; 6(4):439-42. PubMed ID: 25436069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children.
    Skapek SX; Hawk BJ; Hoffer FA; Dahl GV; Granowetter L; Gebhardt MC; Ferguson WS; Grier HE
    J Clin Oncol; 1998 Sep; 16(9):3021-7. PubMed ID: 9738571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful low-dose chemotherapy using vinblastine and methotrexate for the treatment of an ileoanal pouch mesenteric desmoid tumor: report of a case.
    Kono T; Tomita I; Chisato N; Matsuda M; Kakisaka A; Kasai S
    Dis Colon Rectum; 2004 Feb; 47(2):246-9. PubMed ID: 15043298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924.
    Sternberg CN; de Mulder PH; Schornagel JH; Théodore C; Fossa SD; van Oosterom AT; Witjes F; Spina M; van Groeningen CJ; de Balincourt C; Collette L;
    J Clin Oncol; 2001 May; 19(10):2638-46. PubMed ID: 11352955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.